Abbott Laboratories (ABT)

R&D Expenses

$882.00M

Quarterly · Period ending: · USD

ABT logo

ABT R&D Expenses

Latest reported$882.00M
ABT Quarterly R&D Expenses ($0.00 → $882.00M)
High-resolution chart · PNG

ABT r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
397,341,000
318,280,000
349,682,000
318,383,000
361,592,000
321,367,000
335,602,000
276,240,000
314,944,000
267,177,000
342,507,000
292,078,000
307,132,000
279,876,000
375,384,000
326,797,000
320,148,000
280,074,000
352,409,000
278,970,000
304,846,000
268,616,000
282,381,000
255,829,000
287,360,000
247,175,000
252,340,000
239,390,000
244,989,000
226,797,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.